共 104 条
[1]
Jemal A(2008)Cancer statistics, 2008 CA Cancer J Clin 58 71-96
[2]
Siegel R(2005)Management of hepatocellular carcinoma Hepatology 42 1208-1236
[3]
Ward E(2012)European Organisation For Research and Treatment of Cancer EASL-EORTC clinical practice guidelines management of hepatocellular carcinoma J Hepatol 56 908-943
[4]
Bruix J(2010)Current strategy for staging and treatment: the BCLC update and future prospects Semin Liver Dis 30 61-74
[5]
Sherman M(2002)Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 1164-1171
[6]
Forner A(2010)Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma Hepatol Int 4 439-474
[7]
Reig ME(2003)Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429-442
[8]
de Lope CR(1998)Reporting results of cancer treatment Cancer 47 207-214
[9]
Lo CM(2000)New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205-216
[10]
Ngan H(2001)Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421-430